Surfactant protein D deficiency in mice is associated with hyperphagia, altered fat deposition, insulin resistance, and increased basal endotoxemia

PLoS ONE

Volumn 7, Issue 4, 2012, Pages

  Stidsen, Jacob V ^a   Khorooshi, Reza ^a   Rahbek, Martin K U ^a   Kirketerp Møller, Katrine L ^a   Hansen, Pernille B L ^a   Bie, Peter ^a   Kejling, Karin ^a   Mandrup, Susanne ^a   Hawgood, Samuel ^b   Nielsen, Ole ^c   Nielsen, Claus H ^d   Owens, Trevor ^a   Holmskov, Uffe ^a   Sørensen, Grith L ^a  

^a UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c ODENSE UNIVERSITY HOSPITAL   (Denmark)

^d Rigshospitalet   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

AGOUTI RELATED PROTEIN; BACTERIUM LIPOPOLYSACCHARIDE; GLUCOSE; INSULIN; LEPTIN; PROOPIOMELANOCORTIN; SURFACTANT PROTEIN D; FATTY ACID;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOACCUMULATION; BODY FAT DISTRIBUTION; BODY WEIGHT; CALORIC INTAKE; CONTROLLED STUDY; DIET RESTRICTION; DISEASE ASSOCIATION; ENDOTOXEMIA; ENERGY EXPENDITURE; FEMALE; GENE EXPRESSION; HORMONE BLOOD LEVEL; HYPERPHAGIA; INSULIN RESISTANCE; LEPTIN BLOOD LEVEL; LIPID STORAGE; MALE; MEAN ARTERIAL PRESSURE; MOUSE; NONHUMAN; PATHOPHYSIOLOGY; PROTEIN DEFICIENCY; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; WILD TYPE; ADIPOSE TISSUE; ANIMAL; BLOOD; CENTRAL NERVOUS SYSTEM; DRUG EFFECT; ENERGY METABOLISM; GENETICS; GLUCOSE BLOOD LEVEL; INNATE IMMUNITY; LUNG; METABOLISM;

AGOUTI; ANIMALIA; BACTERIA (MICROORGANISMS); MUS;

ADIPOSE TISSUE; ANIMALS; BLOOD GLUCOSE; CENTRAL NERVOUS SYSTEM; ENDOTOXEMIA; ENERGY METABOLISM; FATTY ACIDS, NONESTERIFIED; HYPERPHAGIA; IMMUNITY, INNATE; INSULIN; INSULIN RESISTANCE; LEPTIN; LUNG; MICE; PULMONARY SURFACTANT-ASSOCIATED PROTEIN D;

EID: 84859621564     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0035066     Document Type: Article

References (70)

1. Sorensen GL, Husby S, Holmskov U, (2007) Surfactant protein A and surfactant protein D variation in pulmonary disease. Immunobiology 212: 381-416.
2. Fujita M, Shannon JM, Ouchi H, Voelker DR, Nakanishi Y, et al. (2005) Serum surfactant protein D is increased in acute and chronic inflammation in mice. Cytokine 31: 25-33.
3. Leth-Larsen R, Nordenbaek C, Tornoe I, Moeller V, Schlosser A, et al. (2003) Surfactant protein D (SP-D) serum levels in patients with community-acquired pneumonia. Clin Immunol 108: 29-37.
4. Greene KE, Wright JR, Steinberg KP, Ruzinski JT, Caldwell E, et al. (1999) Serial changes in surfactant-associated proteins in lung and serum before and after onset of ARDS. Am J Respir Crit Care Med 160: 1843-1850.
5. Akiyama J, Hoffman A, Brown C, Allen L, Edmondson J, et al. (2002) Tissue distribution of surfactant proteins A and D in the mouse. J Histochem Cytochem 50: 993-996.
6. Madsen J, Kliem A, Tornoe I, Skjodt K, Koch C, et al. (2000) Localization of lung surfactant protein D on mucosal surfaces in human tissues. J Immunol 164: 5866-5870.
7. Stahlman MT, Gray ME, Hull WM, Whitsett JA, (2002) Immunolocalization of surfactant protein-D (SP-D) in human fetal, newborn, and adult tissues. J Histochem Cytochem 50: 651-660.
8. Fernandez-Real JM, Valdes S, Manco M, Chico B, Botas P, et al. (2010) Surfactant protein d, a marker of lung innate immunity, is positively associated with insulin sensitivity. Diabetes Care 33: 847-853.
9. Sorensen GL, Hjelmborg JV, Leth-Larsen R, Schmidt V, Fenger M, et al. (2006) Surfactant Protein D of the Innate Immune Defence is Inversely Associated with Human Obesity and SP-D Deficiency Infers Increased Body Weight in Mice. Scand J Immunol 64: 633-638.
10. Zhao XM, Wu YP, Wei R, Cai HX, Tornoe I, et al. (2007) Plasma surfactant protein D levels and the relation to body mass index in a chinese population. Scand J Immunol 66: 71-76.
11. Hill J, Heslop C, Man SF, Frohlich J, Connett JE, et al. (2011) Circulating surfactant protein-D and the risk of cardiovascular morbidity and mortality. Eur Heart J 32: 1918-1925.
12. Wannamethee SG, Shaper AG, Rumley A, Sattar N, Whincup PH, et al. (2010) Lung function and risk of type 2 diabetes and fatal and nonfatal major coronary heart disease events: possible associations with inflammation. Diabetes Care 33: 1990-1996.
13. Mancuso P, (2010) Obesity and lung inflammation. J Appl Physiol 108: 722-728.
14. Shore SA, (2008) Obesity and asthma: possible mechanisms. J Allergy Clin Immunol 121: 1087-1093; quiz 1094-1085.
15. Fernandez-Real JM, Pickup JC, (2008) Innate immunity, insulin resistance and type 2 diabetes. Trends Endocrinol Metab 19: 10-16.
16. Hartshorn KL, Crouch E, White MR, Colamussi ML, Kakkanatt A, et al. (1998) Pulmonary surfactant proteins A and D enhance neutrophil uptake of bacteria. Am J Physiol 274: L958-969.
17. Wu H, Kuzmenko A, Wan S, Schaffer L, Weiss A, et al. (2003) Surfactant proteins A and D inhibit the growth of Gram-negative bacteria by increasing membrane permeability. J Clin Invest 111: 1589-1602.
18. Leth-Larsen R, Garred P, Jensenius H, Meschi J, Hartshorn K, et al. (2005) A common polymorphism in the SFTPD gene influences assembly, function, and concentration of surfactant protein D. J Immunol 174: 1532-1538.
19. Yamazoe M, Nishitani C, Takahashi M, Katoh T, Ariki S, et al. (2008) Pulmonary surfactant protein D inhibits lipopolysaccharide (LPS)-induced inflammatory cell responses by altering LPS binding to its receptors. J Biol Chem 283: 35878-35888.
20. Wright JR, (2005) Immunoregulatory functions of surfactant proteins. Nat Rev Immunol 5: 58-68.
21. Yoshida M, Whitsett JA, (2006) Alveolar macrophages and emphysema in surfactant protein-D-deficient mice. Respirology 11 (Suppl): S37-40.
22. Atochina-Vasserman EN, Beers MF, Kadire H, Tomer Y, Inch A, et al. (2007) Selective inhibition of inducible NO synthase activity in vivo reverses inflammatory abnormalities in surfactant protein D-deficient mice. J Immunol 179: 8090-8097.
23. Wouters EF, Creutzberg EC, Schols AM, (2002) Systemic effects in COPD. Chest 121: 127S-130S.
24. Yoshida M, Sakiyama S, Kenzaki K, Toba H, Uyama K, et al. (2009) Functional evaluation of pallid mice with genetic emphysema. Lab Invest 89: 760-768.
25. Creutzberg EC, Casaburi R, (2003) Endocrinological disturbances in chronic obstructive pulmonary disease. Eur Respir J Suppl 46: 76s-80s.
26. Sorensen GL, Madsen J, Kejling K, Tornoe I, Nielsen O, et al. (2006) Surfactant protein D is proatherogenic in mice. Am J Physiol Heart Circ Physiol 290: H2286-2294.
27. Layden BT, Durai V, Newman MV, Marinelarena AM, Ahn CW, et al. (2010) Regulation of pancreatic islet gene expression in mouse islets by pregnancy. J Endocrinol 207: 265-279.
28. Aye T, Toschi E, Sharma A, Sgroi D, Bonner-Weir S, (2010) Identification of markers for newly formed beta-cells in the perinatal period: a time of recognized beta-cell immaturity. J Histochem Cytochem 58: 369-376.
29. Williams KW, Scott MM, Elmquist JK, (2011) Modulation of the central melanocortin system by leptin, insulin, and serotonin: Co-ordinated actions in a dispersed neuronal network. Eur J Pharmacol 660: 2-12.
30. Leinninger GM, (2009) Location, location, location: the CNS sites of leptin action dictate its regulation of homeostatic and hedonic pathways. Int J Obes (Lond) 33 (Suppl 2): S14-17.
31. Odegaard JI, Chawla A, (2011) Alternative macrophage activation and metabolism. Annu Rev Pathol 6: 275-297.
32. Olefsky JM, Glass CK, (2010) Macrophages, inflammation, and insulin resistance. Annu Rev Physiol 72: 219-246.
33. Zeyda M, Stulnig TM, (2007) Adipose tissue macrophages. Immunol Lett 112: 61-67.
34. Cani PD, Amar J, Iglesias MA, Poggi M, Knauf C, et al. (2007) Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes 56: 1761-1772.
35. Brouwer E, Blaxter KL, (1965) Report of sub-commitee on constants and factors. 3rd symposium on energy metabolism in farm animals EAAP-publication 11, London New York Academy Press pp. 441-443.
36. Chwalibog A, Jakobsen K, Henckel S, Thorbek G, (1992) Estimation of Quantitative Oxidation and Fat Retention from Carbohydrate, Protein and Fat in Growing Pigs. Journal of Animal Physiology and Animal Nutrition-Zeitschrift für Tierphysiologie Tierernahrung und Füttermittelkunde 68: 122-135.
37. Andersen H, Jaff MG, Hogh D, Vanhoutte P, Hansen PB, (2011) Adenosine elicits an eNOS-independent reduction in arterial blood pressure in conscious mice that involves adenosine A2A receptors. Acta Physiol (Oxf) 203: 197-207.
38. Sorensen GL, Hoegh SV, Leth-Larsen R, Thomsen TH, Floridon C, et al. (2009) Multimeric and trimeric subunit SP-D are interconvertible structures with distinct ligand interaction. Mol Immunol 46: 3060-3069.
39. Paxinox G, Franklin KBJ, (2001) The mouse brain in stereotaxic coordinates, 2nd edition, San Diego, Calif.; London.
40. Guo CJ, Atochina-Vasserman EN, Abramova E, Foley JP, Zaman A, et al. (2008) S-Nitrosylation of Surfactant Protein-D Controls Inflammatory Function. PLoS Biol 6: e266.
41. Khorooshi R, Owens T, (2010) Injury-induced type I IFN signaling regulates inflammatory responses in the central nervous system. J Immunol 185: 1258-1264.
42. Gundersen HJ, Bagger P, Bendtsen TF, Evans SM, Korbo L, et al. (1988) The new stereological tools: disector, fractionator, nucleator and point sampled intercepts and their use in pathological research and diagnosis. APMIS 96: 857-881.
43. Gundersen HJ, Bendtsen TF, Korbo L, Marcussen N, Moller A, et al. (1988) Some new, simple and efficient stereological methods and their use in pathological research and diagnosis. APMIS 96: 379-394.
44. Breslow MJ, Min-Lee K, Brown DR, Chacko VP, Palmer D, et al. (1999) Effect of leptin deficiency on metabolic rate in ob/ob mice. Am J Physiol 276: E443-449.
45. Ste Marie L, Miura GI, Marsh DJ, Yagaloff K, Palmiter RD, (2000) A metabolic defect promotes obesity in mice lacking melanocortin-4 receptors. Proc Natl Acad Sci U S A 97: 12339-12344.
46. Weide K, Christ N, Moar KM, Arens J, Hinney A, et al. (2003) Hyperphagia, not hypometabolism, causes early onset obesity in melanocortin-4 receptor knockout mice. Physiol Genomics 13: 47-56.
47. Brown LM, Clegg DJ, Benoit SC, Woods SC, (2006) Intraventricular insulin and leptin reduce food intake and body weight in C57BL/6J mice. Physiol Behav 89: 687-691.
48. Reed JA, Clegg DJ, Smith KB, Tolod-Richer EG, Matter EK, et al. (2005) GM-CSF action in the CNS decreases food intake and body weight. J Clin Invest 115: 3035-3044.
49. Ahima RS, Patel HR, Takahashi N, Qi Y, Hileman SM, et al. (2002) Appetite suppression and weight reduction by a centrally active aminosterol. Diabetes 51: 2099-2104.
50. Honda K, Kamisoyama H, Saneyasu T, Sugahara K, Hasegawa S, (2007) Central administration of insulin suppresses food intake in chicks. Neurosci Lett 423: 153-157.
51. Ikegami M, Hull WM, Yoshida M, Wert SE, Whitsett JA, (2001) SP-D and GM-CSF regulate surfactant homeostasis via distinct mechanisms. Am J Physiol Lung Cell Mol Physiol 281: L697-703.
52. Sorensen GL, Hjelmborg JB, Kyvik KO, Fenger M, Hoj A, et al. (2006) Genetic and environmental influences of surfactant protein D serum levels. Am J Physiol Lung Cell Mol Physiol 290: L1010-1017.
53. Tilg H, Moschen AR, (2008) Role of adiponectin and PBEF/visfatin as regulators of inflammation: involvement in obesity-associated diseases. Clin Sci (Lond) 114: 275-288.
54. Onat A, Can G, Rezvani R, Cianflone K, (2011) Complement C3 and cleavage products in cardiometabolic risk. Clin Chim Acta.
55. Zhang M, Zhao X, Li M, Cheng H, Hou D, et al. (2011) Abnormal adipokines associated with various types of obesity in chinese children and adolescents. Biomed Environ Sci 24: 12-21.
56. Fain JN, Madan AK, Hiler ML, Cheema P, Bahouth SW, (2004) Comparison of the release of adipokines by adipose tissue, adipose tissue matrix, and adipocytes from visceral and subcutaneous abdominal adipose tissues of obese humans. Endocrinology 145: 2273-2282.
57. von Eyben FE, Mouritsen E, Holm J, Montvilas P, Dimcevski G, et al. (2003) Intra-abdominal obesity and metabolic risk factors: a study of young adults. Int J Obes Relat Metab Disord 27: 941-949.
58. Hamdy O, Porramatikul S, Al-Ozairi E, (2006) Metabolic obesity: the paradox between visceral and subcutaneous fat. Curr Diabetes Rev 2: 367-373.
59. Backhed F, Ding H, Wang T, Hooper LV, Koh GY, et al. (2004) The gut microbiota as an environmental factor that regulates fat storage. Proc Natl Acad Sci U S A 101: 15718-15723.
60. Ley RE, Backhed F, Turnbaugh P, Lozupone CA, Knight RD, et al. (2005) Obesity alters gut microbial ecology. Proc Natl Acad Sci U S A 102: 11070-11075.
61. Ley RE, Turnbaugh PJ, Klein S, Gordon JI, (2006) Microbial ecology: human gut microbes associated with obesity. Nature 444: 1022-1023.
62. Turnbaugh PJ, Hamady M, Yatsunenko T, Cantarel BL, Duncan A, et al. (2009) A core gut microbiome in obese and lean twins. Nature 457: 480-484.
63. Turnbaugh PJ, Ley RE, Mahowald MA, Magrini V, Mardis ER, et al. (2006) An obesity-associated gut microbiome with increased capacity for energy harvest. Nature 444: 1027-1031.
64. Conterno L, Fava F, Viola R, Tuohy KM, (2011) Obesity and the gut microbiota: does up-regulating colonic fermentation protect against obesity and metabolic disease? Genes Nutr 6: 241-260.
65. Vijay-Kumar M, Aitken JD, Carvalho FA, Cullender TC, Mwangi S, et al. (2010) Metabolic syndrome and altered gut microbiota in mice lacking Toll-like receptor 5. Science 328: 228-231.
66. Tsukumo DM, Carvalho-Filho MA, Carvalheira JB, Prada PO, Hirabara SM, et al. (2007) Loss-of-function mutation in Toll-like receptor 4 prevents diet-induced obesity and insulin resistance. Diabetes 56: 1986-1998.
67. Frisard MI, McMillan RP, Marchand J, Wahlberg KA, Wu Y, et al. (2010) Toll-like receptor 4 modulates skeletal muscle substrate metabolism. Am J Physiol Endocrinol Metab 298: E988-998.
68. Hansen S, Schmidt V, Steffensen MA, Jensen PH, Gjerstorff M, et al. (2008) An enzyme-linked immunosorbent assay (ELISA) for quantification of mouse surfactant protein D (SP-D). J Immunol Methods 330: 75-85.
69. Sano H, Chiba H, Iwaki D, Sohma H, Voelker DR, et al. (2000) Surfactant proteins A and D bind CD14 by different mechanisms. J Biol Chem 275: 22442-22451.
70. Ohya M, Nishitani C, Sano H, Yamada C, Mitsuzawa H, et al. (2006) Human Pulmonary Surfactant Protein D Binds the Extracellular Domains of Toll-like Receptors 2 and 4 through the Carbohydrate Recognition Domain by a Mechanism Different from Its Binding to Phosphatidylinositol and Lipopolysaccharide. Biochemistry 45: 8657-8664.